The American Express Global Business Travel (Amex GBT) has announced record-breaking growth in 2025, driven by its strategic use of artificial intelligence (AI). In a recent conference call, the ...

The Yalla Group Limited's fourth quarter and full year 2025 earnings conference call revealed a company poised to seize ...

Concrete Pumping Holdings, a leading provider of concrete pumping services, has reported a strong first quarter for 2026, with revenue increasing by 5% year-over-year and adjusted EBITDA up 6%.

SGIA, a leading provider of smallpox antiviral treatment, has reported solid financial results for the fourth quarter of 2025. The company delivered strong revenues and continued to strengthen its ...

Greenlight Capital Re, Ltd. recently announced its Fourth Quarter 2025 earnings, delivering strong results that reflect the company's confidence in its strategy and positioning. Greg Richardson, Chief ...

On March 10th, Kohl's Corporation took center stage as the company announced its fourth quarter earnings for 2025. Amidst a tumultuous retail landscape, Kohl's stood tall, showcasing resilience and ...

TransAct Technologies, a leading provider of software-based business solutions for the restaurant industry, has reported a strong fourth quarter performance in its latest earnings call. The company's ...

Custom Truck One Source, a leading provider of rental and sales solutions for heavy equipment, announced a stellar finish to 2025 with record quarterly revenue driven by sustained momentum in its core ...

On March 10th, Exagen Incorporated held its fourth-quarter earnings call for 2025, shedding light on the company's remarkable progress in revolutionizing autoimmune disease diagnosis. The conference ...

Optical Cable Corporation (OCC) has kicked off fiscal year 2026 with a resounding start, delivering impressive net sales and gross profit growth in its first quarter. The company's strong performance ...

Grid Dynamics, a leading technology company specializing in AI-powered solutions, has ended the year 2025 on a high note by crushing Wall Street expectations on both revenue and EBITDA. In its recent ...

Esperion Therapeutics, a leading player in the cardiometabolic disease space, has just concluded its Q4 2025 earnings conference call, and the news is nothing short of exciting. The company, led by ...